August 12. 2009 Distribution agreement with Forensic Pathways

NarTest signed a distribution agreement with Forensic Pathways for representing NarTest NTX2000 Drug Analyzer throughout the United Kingdom, Ireland and Australia.

Markku Mäenpää, CEO and President of NarTest AS, announced the signed distribution agreement with Forensic Pathways, located in Staffordshire, England.

Forensic Pathways has the depth of sales and technical expertise to support international sales of a unique product based on patented technology, which combines the method of Spectral Fluorescence Signatures (SFS) and pattern recognition for fast detection of illicit drugs in seized street samples.

About Forensic Pathways

Forensic Pathways is an award winning international company specialising in offering unique data analysis solutions in the area of criminal intelligence, due diligence/risk and business intelligence and is internationally recognised for taking a lead in the development of forensic products/services.

About NarTest

NarTest is a leading manufacturer of drug analyzing instruments using spectral fluorescence signature technology to rapidly identify known drugs including marijuana, cocaine, amphetamine, methamphetamine, heroin and ecstasy. We make our affordable and accurate system available to law enforcement and drug interdiction agencies worldwide.

Source: NarTest AS